APA

Nebuloni D. R., Mak M. P., Souza F. H., Saragiotto D. F., Júlio T., DE Castro G., Sabbaga J. & Hoff P. M. (2013). Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis. : Molecular and clinical oncology.

Chicago

Nebuloni Daniela R, Mak Milena P, Souza Fabiano Hahn, Saragiotto Daniel F, Júlio Thiago, DE Castro Gilberto, Sabbaga Jorge and Hoff Paulo M. 2013. Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis. : Molecular and clinical oncology.

Harvard

Nebuloni D. R., Mak M. P., Souza F. H., Saragiotto D. F., Júlio T., DE Castro G., Sabbaga J. and Hoff P. M. (2013). Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis. : Molecular and clinical oncology.

MLA

Nebuloni Daniela R, Mak Milena P, Souza Fabiano Hahn, Saragiotto Daniel F, Júlio Thiago, DE Castro Gilberto, Sabbaga Jorge and Hoff Paulo M. Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis. : Molecular and clinical oncology. 2013.